{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T16:22:37Z","timestamp":1772209357857,"version":"3.50.1"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/110.678\/2012"],"award-info":[{"award-number":["E-26\/110.678\/2012"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/110.435\/2014"],"award-info":[{"award-number":["E-26\/110.435\/2014"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00213-020-05485-0","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T09:06:04Z","timestamp":1582535164000},"page":"1643-1655","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effects of combined 5-HT2A and cannabinoid receptor modulation on a schizophrenia-related prepulse inhibition deficit in mice"],"prefix":"10.1007","volume":"237","author":[{"given":"Adriana M.","family":"Marques","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele V.","family":"Macena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline R.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila S. O.","family":"Hammes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda M. L.","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9570-7428","authenticated-orcid":false,"given":"Newton G.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7027-3851","authenticated-orcid":false,"given":"Gilda A.","family":"Neves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,24]]},"reference":[{"key":"5485_CR1","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0006-3223(97)00556-8","volume":"43","author":"C Adler","year":"1998","unstructured":"Adler C, Goldberg T, Malhotra A et al (1998) Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers. Biol Psychiatry 43:811\u2013816. https:\/\/doi.org\/10.1016\/S0006-3223(97)00556-8","journal-title":"Biol Psychiatry"},{"key":"5485_CR2","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1038\/sj.npp.1301344","volume":"32","author":"M Ballmaier","year":"2007","unstructured":"Ballmaier M, Bortolato M, Rizzetti C et al (2007) Cannabinoid receptor antagonists counteract sensorimotor gating deficits in the phencyclidine model of psychosis. Neuropsychopharmacology 32:2098\u20132107. https:\/\/doi.org\/10.1038\/sj.npp.1301344","journal-title":"Neuropsychopharmacology"},{"key":"5485_CR3","doi-asserted-by":"publisher","first-page":"11700","DOI":"10.1523\/jneurosci.1636-07.2007","volume":"27","author":"FR Bambico","year":"2007","unstructured":"Bambico FR, Katz N, Debonnel G, Gobbi G (2007) Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. J Neurosci 27:11700\u201311711. https:\/\/doi.org\/10.1523\/jneurosci.1636-07.2007","journal-title":"J Neurosci"},{"key":"5485_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/sj.npp.1300343","volume":"29","author":"AM Barr","year":"2004","unstructured":"Barr AM, Lehmann-Masten V, Paulus M et al (2004) The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice. Neuropsychopharmacology 29:221\u2013228. https:\/\/doi.org\/10.1038\/sj.npp.1300343","journal-title":"Neuropsychopharmacology"},{"key":"5485_CR5","doi-asserted-by":"publisher","first-page":"6508","DOI":"10.1523\/JNEUROSCI.0678-08.2008","volume":"28","author":"AR Best","year":"2008","unstructured":"Best AR, Regehr WG (2008) Serotonin evokes endocannabinoid release and retrogradely suppresses excitatory synapses. J Neurosci 28:6508\u20136515. https:\/\/doi.org\/10.1523\/JNEUROSCI.0678-08.2008","journal-title":"J Neurosci"},{"key":"5485_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.schres.2011.11.009","volume":"134","author":"DL Boggs","year":"2012","unstructured":"Boggs DL, Kelly DL, McMahon RP et al (2012) Rimonabant for neurocognition in schizophrenia: a 16-week double blind randomized placebo controlled trial. Schizophr Res 134:207\u2013210. https:\/\/doi.org\/10.1016\/j.schres.2011.11.009","journal-title":"Schizophr Res"},{"key":"5485_CR7","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s00213-004-1941-4","volume":"177","author":"M Bortolato","year":"2005","unstructured":"Bortolato M, Aru GN, Frau R et al (2005) The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague-Dawley rats. Psychopharmacology 177:264\u2013271. https:\/\/doi.org\/10.1007\/s00213-004-1941-4","journal-title":"Psychopharmacology"},{"key":"5485_CR8","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1038\/sj.npp.1301061","volume":"31","author":"M Bortolato","year":"2006","unstructured":"Bortolato M, Campolongo P, Mangieri RA et al (2006) Anxiolytic-like properties of the anandamide transport inhibitor AM404. Neuropsychopharmacology 31:2652\u20132659. https:\/\/doi.org\/10.1038\/sj.npp.1301061","journal-title":"Neuropsychopharmacology"},{"key":"5485_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1001\/archpsyc.1990.01810140081011","volume":"47","author":"DL Braff","year":"1990","unstructured":"Braff DL, Geyer MA (1990) Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 47:181\u2013188","journal-title":"Arch Gen Psychiatry"},{"key":"5485_CR10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.1469-8986.1978.tb01390.x","volume":"15","author":"D Braff","year":"1978","unstructured":"Braff D, Stone C, Callaway E et al (1978) Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15:339\u2013343","journal-title":"Psychophysiology"},{"key":"5485_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00213-003-1635-3","volume":"172","author":"SA Brody","year":"2004","unstructured":"Brody SA, Conquet F, Geyer MA (2004) Effect of antipsychotic treatment on the prepulse inhibition deficit of mGluR5 knockout mice. Psychopharmacology 172:187\u2013195. https:\/\/doi.org\/10.1007\/s00213-003-1635-3","journal-title":"Psychopharmacology"},{"key":"5485_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/J.PBB.2011.03.017","volume":"99","author":"J Brosda","year":"2011","unstructured":"Brosda J, Hayn L, Klein C et al (2011) Pharmacological and parametrical investigation of prepulse inhibition of startle and prepulse elicited reactions in Wistar rats. Pharmacol Biochem Behav 99:22\u201328. https:\/\/doi.org\/10.1016\/J.PBB.2011.03.017","journal-title":"Pharmacol Biochem Behav"},{"key":"5485_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/J.BBR.2010.11.003","volume":"218","author":"MM Brz\u00f3zka","year":"2011","unstructured":"Brz\u00f3zka MM, Fischer A, Falkai P, Havemann-Reinecke U (2011) Acute treatment with cannabinoid receptor agonist WIN55212.2 improves prepulse inhibition in psychosocially stressed mice. Behav Brain Res 218:280\u2013287. https:\/\/doi.org\/10.1016\/J.BBR.2010.11.003","journal-title":"Behav Brain Res"},{"key":"5485_CR14","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.neuropharm.2006.11.004","volume":"52","author":"V Buben\u00edkov\u00e1-Vale\u0161ov\u00e1","year":"2007","unstructured":"Buben\u00edkov\u00e1-Vale\u0161ov\u00e1 V, Votava M, P\u00e1len\u00ed\u010dek T, Hor\u00e1\u010dek J (2007) The opposite effect of a low and a high dose of serotonin-1A agonist on behavior induced by MK-801. Neuropharmacology 52:1071\u20131078. https:\/\/doi.org\/10.1016\/j.neuropharm.2006.11.004","journal-title":"Neuropharmacology"},{"key":"5485_CR15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.psychres.2017.09.016","volume":"262","author":"CH Cheng","year":"2018","unstructured":"Cheng CH, Chan PYS, Hsu SC, Liu CY (2018) Meta-analysis of sensorimotor gating in patients with autism spectrum disorders. Psychiatry Res 262:413\u2013419. https:\/\/doi.org\/10.1016\/j.psychres.2017.09.016","journal-title":"Psychiatry Res"},{"key":"5485_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0140-6736(13)62106-6","volume":"383","author":"J Cummings","year":"2014","unstructured":"Cummings J, Isaacson S, Mills R et al (2014) Pimavanserin for patients with Parkinson\u2019s disease psychosis: a randomised, placebo-controlled phase 3 trial. Lancet (London, England) 383:533\u2013540. https:\/\/doi.org\/10.1016\/S0140-6736(13)62106-6","journal-title":"Lancet (London, England)"},{"key":"5485_CR17","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/J.BIOPSYCH.2004.12.006","volume":"57","author":"DC D\u2019Souza","year":"2005","unstructured":"D\u2019Souza DC, Abi-Saab WM, Madonick S et al (2005) Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol Psychiatry 57:594\u2013608. https:\/\/doi.org\/10.1016\/J.BIOPSYCH.2004.12.006","journal-title":"Biol Psychiatry"},{"key":"5485_CR18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0091-3057(00)00477-9","volume":"68","author":"NA Darmani","year":"2001","unstructured":"Darmani NA (2001) Cannabinoids of diverse structure inhibit two DOI-induced 5-HT2A receptor-mediated behaviors in mice. Pharmacol Biochem Behav 68:311\u2013317. https:\/\/doi.org\/10.1016\/S0091-3057(00)00477-9","journal-title":"Pharmacol Biochem Behav"},{"key":"5485_CR19","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s007020070043","volume":"107","author":"NA Darmani","year":"2000","unstructured":"Darmani NA, Pandya DK (2000) Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice. J Neural Transm 107:931\u2013945. https:\/\/doi.org\/10.1007\/s007020070043","journal-title":"J Neural Transm"},{"key":"5485_CR20","first-page":"123","volume":"2","author":"T de Paulis","year":"2001","unstructured":"de Paulis T (2001) M-100907 (Aventis). Curr Opin Investig Drugs 2:123\u2013132","journal-title":"Curr Opin Investig Drugs"},{"key":"5485_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0306-4522(00)00552-2","volume":"103","author":"B Dean","year":"2001","unstructured":"Dean B, Sundram S, Bradbury R et al (2001) Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience 103:9\u201315. https:\/\/doi.org\/10.1016\/S0306-4522(00)00552-2","journal-title":"Neuroscience"},{"key":"5485_CR22","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/S0893-133X(99)00164-5","volume":"22","author":"SC Dulawa","year":"2000","unstructured":"Dulawa SC, Gross C, Stark KL et al (2000) Knockout mice reveal opposite roles for serotonin 1A and 1B receptors in prepulse inhibition. Neuropsychopharmacology 22:650\u2013659. https:\/\/doi.org\/10.1016\/S0893-133X(99)00164-5","journal-title":"Neuropsychopharmacology"},{"key":"5485_CR23","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/archpsyc.65.7.772","volume":"65","author":"SM Eggan","year":"2008","unstructured":"Eggan SM, Hashimoto T, Lewis DA (2008) Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. Arch Gen Psychiatry 65:772\u2013784. https:\/\/doi.org\/10.1001\/archpsyc.65.7.772","journal-title":"Arch Gen Psychiatry"},{"key":"5485_CR24","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1038\/npp.2010.75","volume":"35","author":"SM Eggan","year":"2010","unstructured":"Eggan SM, Stoyak SR, Verrico CD, Lewis DA (2010) Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: comparison of schizophrenia and major depressive disorder. Neuropsychopharmacology 35:2060\u20132071. https:\/\/doi.org\/10.1038\/npp.2010.75","journal-title":"Neuropsychopharmacology"},{"key":"5485_CR25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/03602532.2018.1428343","volume":"50","author":"WE Fantegrossi","year":"2018","unstructured":"Fantegrossi WE, Wilson CD, Berquist MD (2018) Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems. Drug Metab Rev 50:65\u201373. https:\/\/doi.org\/10.1080\/03602532.2018.1428343","journal-title":"Drug Metab Rev"},{"key":"5485_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/BF03033358","volume":"10","author":"MA Geyer","year":"2006","unstructured":"Geyer MA (2006) The family of sensorimotor gating disorders: comorbidities or diagnostic overlaps? Neurotox Res 10:211\u2013220","journal-title":"Neurotox Res"},{"key":"5485_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s002130100811","volume":"156","author":"MA Geyer","year":"2001","unstructured":"Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156:117\u2013154","journal-title":"Psychopharmacology"},{"key":"5485_CR28","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/sj.bjp.0707148","volume":"150","author":"A Gogos","year":"2007","unstructured":"Gogos A, Van Den Buuse M (2007) The importance of baseline in identifying 8-OH-DPAT-induced effects on prepulse inhibition in rats. Br J Pharmacol 150:750\u2013757. https:\/\/doi.org\/10.1038\/sj.bjp.0707148","journal-title":"Br J Pharmacol"},{"key":"5485_CR29","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/sj.npp.1300933","volume":"31","author":"A Gogos","year":"2006","unstructured":"Gogos A, Nathan PJ, Guille V et al (2006) Estrogen prevents 5-HT1A receptor-induced disruptions of prepulse inhibition in healthy women. Neuropsychopharmacology 31:885\u2013889. https:\/\/doi.org\/10.1038\/sj.npp.1300933","journal-title":"Neuropsychopharmacology"},{"key":"5485_CR30","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/FBP.0b013e32830cd822","volume":"19","author":"A Gogos","year":"2008","unstructured":"Gogos A, Bogeski M, Van Den Buuse M (2008) Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology. Behav Pharmacol 19:548\u2013561. https:\/\/doi.org\/10.1097\/FBP.0b013e32830cd822","journal-title":"Behav Pharmacol"},{"key":"5485_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejphar.2005.04.019","volume":"516","author":"BB Gorzalka","year":"2005","unstructured":"Gorzalka BB, Hill MN, Sun JC (2005) Functional role of the endocannabinoid system and AMPA\/kainate receptors in 5-HT2A receptor-mediated wet dog shakes. Eur J Pharmacol 516:28\u201333. https:\/\/doi.org\/10.1016\/j.ejphar.2005.04.019","journal-title":"Eur J Pharmacol"},{"key":"5485_CR32","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.neuropharm.2011.02.016","volume":"61","author":"S Haj-Dahmane","year":"2011","unstructured":"Haj-Dahmane S, Shen RY (2011) Modulation of the serotonin system by endocannabinoid signaling. Neuropharmacology 61:414\u2013420. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.02.016","journal-title":"Neuropharmacology"},{"key":"5485_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00213-009-1718-x","volume":"208","author":"AL Halberstadt","year":"2010","unstructured":"Halberstadt AL, Geyer MA (2010) LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor. Psychopharmacology 208:179\u2013189. https:\/\/doi.org\/10.1007\/s00213-009-1718-x","journal-title":"Psychopharmacology"},{"key":"5485_CR34","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1017\/S1461145713000722","volume":"16","author":"AL Halberstadt","year":"2013","unstructured":"Halberstadt AL, Geyer MA (2013) Serotonergic hallucinogens as translational models relevant to schizophrenia. Int J Neuropsychopharmacol 16:2165\u20132180. https:\/\/doi.org\/10.1017\/S1461145713000722","journal-title":"Int J Neuropsychopharmacol"},{"key":"5485_CR35","first-page":"159","volume-title":"Effect of hallucinogens on unconditioned behavior","author":"AL Halberstadt","year":"2016","unstructured":"Halberstadt AL, Geyer MA (2016) Effect of hallucinogens on unconditioned behavior. Springer, Berlin, Heidelberg, pp 159\u2013199"},{"key":"5485_CR36","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/J.NEUROSCIENCE.2007.02.021","volume":"146","author":"M H\u00e4ring","year":"2007","unstructured":"H\u00e4ring M, Marsicano G, Lutz B, Monory K (2007) Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice. Neuroscience 146:1212\u20131219. https:\/\/doi.org\/10.1016\/J.NEUROSCIENCE.2007.02.021","journal-title":"Neuroscience"},{"key":"5485_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neuropharm.2012.09.002","volume":"65","author":"M H\u00e4ring","year":"2013","unstructured":"H\u00e4ring M, Grieb M, Monory K et al (2013) Cannabinoid CB1 receptor in the modulation of stress coping behavior in mice: the role of serotonin and different forebrain neuronal subpopulations. Neuropharmacology 65:83\u201389. https:\/\/doi.org\/10.1016\/j.neuropharm.2012.09.002","journal-title":"Neuropharmacology"},{"key":"5485_CR38","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.biopsych.2005.01.040","volume":"57","author":"K Hoenig","year":"2005","unstructured":"Hoenig K, Hochrein A, Quednow BB et al (2005) Impaired prepulse inhibition of acoustic startle in obsessive-compulsive disorder. Biol Psychiatry 57:1153\u20131158. https:\/\/doi.org\/10.1016\/j.biopsych.2005.01.040","journal-title":"Biol Psychiatry"},{"key":"5485_CR39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/0269881114563634","volume":"29","author":"O Howes","year":"2015","unstructured":"Howes O, McCutcheon R, Stone J (2015) Glutamate and dopamine in schizophrenia: an update for the 21st century. J Psychopharmacol 29:97\u2013115. https:\/\/doi.org\/10.1177\/0269881114563634","journal-title":"J Psychopharmacol"},{"key":"5485_CR40","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0014-2999(94)90813-3","volume":"271","author":"SP Hume","year":"1994","unstructured":"Hume SP, Ashworth S, Opacka-Juffry J et al (1994) Evaluation of [O-methyl-3H]WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brain. Eur J Pharmacol 271:515\u2013523. https:\/\/doi.org\/10.1016\/0014-2999(94)90813-3","journal-title":"Eur J Pharmacol"},{"key":"5485_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0091-3057(01)00647-5","volume":"71","author":"JJ Janoyan","year":"2002","unstructured":"Janoyan JJ, Crim JL, Darmani NA (2002) Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by \u03949-THC and other cannabinoids. Pharmacol Biochem Behav 71:155\u2013162. https:\/\/doi.org\/10.1016\/S0091-3057(01)00647-5","journal-title":"Pharmacol Biochem Behav"},{"key":"5485_CR42","first-page":"12","volume":"9","author":"DC Javitt","year":"1987","unstructured":"Javitt DC (1987) Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. Hillside J Clin Psychiatry 9:12\u201335","journal-title":"Hillside J Clin Psychiatry"},{"key":"5485_CR43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/J.SCHRES.2012.07.021","volume":"141","author":"KJ Jenko","year":"2012","unstructured":"Jenko KJ, Hirvonen J, Henter ID et al (2012) Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia. Schizophr Res 141:185\u2013188. https:\/\/doi.org\/10.1016\/J.SCHRES.2012.07.021","journal-title":"Schizophr Res"},{"key":"5485_CR44","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/JCP.0b013e318204825b","volume":"31","author":"DL Kelly","year":"2011","unstructured":"Kelly DL, Gorelick DA, Conley RR et al (2011) Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study. J Clin Psychopharmacol 31:86\u201391. https:\/\/doi.org\/10.1097\/JCP.0b013e318204825b","journal-title":"J Clin Psychopharmacol"},{"key":"5485_CR45","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.1523\/jneurosci.19-13-05644.1999","volume":"19","author":"GG Kinney","year":"2018","unstructured":"Kinney GG, Wilkinson LO, Saywell KL, Tricklebank MD (2018) Rat strain differences in the ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity. J Neurosci 19:5644\u20135653. https:\/\/doi.org\/10.1523\/jneurosci.19-13-05644.1999","journal-title":"J Neurosci"},{"key":"5485_CR46","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s00210-004-0951-4","volume":"370","author":"AR Knight","year":"2004","unstructured":"Knight AR, Misra A, Quirk K et al (2004) Pharmacological characterisation of the agonist radioligand binding site of 5-HT2A, 5-HT2B and 5-HT2C receptors. Naunyn Schmiedeberg's Arch Pharmacol 370:114\u2013123. https:\/\/doi.org\/10.1007\/s00210-004-0951-4","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"5485_CR47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00213-009-1506-7","volume":"205","author":"B Le Foll","year":"2009","unstructured":"Le Foll B, Gorelick DA, Goldberg SR (2009) The future of endocannabinoid-oriented clinical research after CB1 antagonists. Psychopharmacology 205:171\u2013174. https:\/\/doi.org\/10.1007\/s00213-009-1506-7","journal-title":"Psychopharmacology"},{"key":"5485_CR48","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fphar.2014.00010","volume":"5","author":"R Levin","year":"2014","unstructured":"Levin R, Peres FF, Almeida V et al (2014) Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain. Front Pharmacol 5:10. https:\/\/doi.org\/10.3389\/fphar.2014.00010","journal-title":"Front Pharmacol"},{"key":"5485_CR49","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/J.TINS.2008.02.005","volume":"31","author":"JE Lisman","year":"2008","unstructured":"Lisman JE, Coyle JT, Green RW et al (2008) Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci 31:234\u2013242. https:\/\/doi.org\/10.1016\/J.TINS.2008.02.005","journal-title":"Trends Neurosci"},{"key":"5485_CR50","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/PL00005075","volume":"356","author":"JF L\u00f3pez-Gim\u00e9nez","year":"1997","unstructured":"L\u00f3pez-Gim\u00e9nez JF, Mengod G, Palacios JM, Vilar\u00f3 MT (1997) Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907. Naunyn Schmiedeberg's Arch Pharmacol 356:446\u2013454","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"5485_CR51","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/J.PBB.2005.02.017","volume":"81","author":"T Lundqvist","year":"2005","unstructured":"Lundqvist T (2005) Cognitive consequences of cannabis use: Comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacol Biochem Behav 81:319\u2013330. https:\/\/doi.org\/10.1016\/J.PBB.2005.02.017","journal-title":"Pharmacol Biochem Behav"},{"key":"5485_CR52","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bbr.2005.07.009","volume":"166","author":"DT Malone","year":"2006","unstructured":"Malone DT, Taylor DA (2006) The effect of \u03949-tetrahydrocannabinol on sensorimotor gating in socially isolated rats. Behav Brain Res 166:101\u2013109. https:\/\/doi.org\/10.1016\/j.bbr.2005.07.009","journal-title":"Behav Brain Res"},{"key":"5485_CR53","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.pbb.2004.02.010","volume":"77","author":"DT Malone","year":"2004","unstructured":"Malone DT, Long LE, Taylor DA (2004) The effect of SR 141716 and apomorphine on sensorimotor gating in Swiss mice. Pharmacol Biochem Behav 77:839\u2013845. https:\/\/doi.org\/10.1016\/j.pbb.2004.02.010","journal-title":"Pharmacol Biochem Behav"},{"key":"5485_CR54","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/BF02247436","volume":"124","author":"RS Mansbach","year":"1996","unstructured":"Mansbach RS, Rovetti CC, Winston EN, Lowe JA (1996) Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats. Psychopharmacology 124:315\u2013322. https:\/\/doi.org\/10.1007\/BF02247436","journal-title":"Psychopharmacology"},{"key":"5485_CR55","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00008877-200402000-00003","volume":"15","author":"EM Marco","year":"2004","unstructured":"Marco EM, P\u00e9rez-Alvarez L, Borcel E et al (2004) Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats. Behav Pharmacol 15:21\u201327","journal-title":"Behav Pharmacol"},{"key":"5485_CR56","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s00213-002-1240-x","volume":"165","author":"RS Martin","year":"2003","unstructured":"Martin RS, Secchi RL, Sung E et al (2003) Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat. Psychopharmacology 165:128\u2013135. https:\/\/doi.org\/10.1007\/s00213-002-1240-x","journal-title":"Psychopharmacology"},{"key":"5485_CR57","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/cne.903270406","volume":"327","author":"LA Matsuda","year":"1993","unstructured":"Matsuda LA, Bonner TI, Lolait SJ (1993) Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 327:535\u2013550. https:\/\/doi.org\/10.1002\/cne.903270406","journal-title":"J Comp Neurol"},{"key":"5485_CR58","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","volume":"64","author":"R Mechoulam","year":"2013","unstructured":"Mechoulam R, Parker LA (2013) The endocannabinoid system and the brain. Annu Rev Psychol 64:21\u201347. https:\/\/doi.org\/10.1146\/annurev-psych-113011-143739","journal-title":"Annu Rev Psychol"},{"key":"5485_CR59","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/J.COPH.2011.02.007","volume":"11","author":"H Meltzer","year":"2011","unstructured":"Meltzer H, Massey B (2011) The role of serotonin receptors in the action of atypical antipsychotic drugs. Curr Opin Pharmacol 11:59\u201367. https:\/\/doi.org\/10.1016\/J.COPH.2011.02.007","journal-title":"Curr Opin Pharmacol"},{"key":"5485_CR60","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1176\/appi.ajp.161.6.975","volume":"161","author":"HY Meltzer","year":"2004","unstructured":"Meltzer HY, Arvanitis L, Bauer D et al (2004) Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder. Am J Psychiatry 161:975\u2013984. https:\/\/doi.org\/10.1176\/appi.ajp.161.6.975","journal-title":"Am J Psychiatry"},{"key":"5485_CR61","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/J.PSYCHRES.2014.08.010","volume":"220","author":"I Morales-Mu\u00f1oz","year":"2014","unstructured":"Morales-Mu\u00f1oz I, Jurado-Barba R, Ponce G et al (2014) Characterizing cannabis-induced psychosis: a study with prepulse inhibition of the startle reflex. Psychiatry Res 220:535\u2013540. https:\/\/doi.org\/10.1016\/J.PSYCHRES.2014.08.010","journal-title":"Psychiatry Res"},{"key":"5485_CR62","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1177\/0269881117711920","volume":"31","author":"I Morales-Mu\u00f1oz","year":"2017","unstructured":"Morales-Mu\u00f1oz I, Mart\u00ednez-Gras I, Ponce G et al (2017) Psychological symptomatology and impaired prepulse inhibition of the startle reflex are associated with cannabis-induced psychosis. J Psychopharmacol 31:1035\u20131045. https:\/\/doi.org\/10.1177\/0269881117711920","journal-title":"J Psychopharmacol"},{"key":"5485_CR63","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1369-1600.2008.00104.x","volume":"13","author":"FA Moreira","year":"2008","unstructured":"Moreira FA, Lutz B (2008) The endocannabinoid system: emotion, learning and addiction. Addict Biol 13:196\u2013212. https:\/\/doi.org\/10.1111\/j.1369-1600.2008.00104.x","journal-title":"Addict Biol"},{"key":"5485_CR64","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/J.PBB.2006.05.018","volume":"84","author":"H Nagai","year":"2006","unstructured":"Nagai H, Egashira N, Sano K et al (2006) Antipsychotics improve \u03949-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice. Pharmacol Biochem Behav 84:330\u2013336. https:\/\/doi.org\/10.1016\/J.PBB.2006.05.018","journal-title":"Pharmacol Biochem Behav"},{"key":"5485_CR65","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.schres.2019.02.018","volume":"208","author":"HA Nasrallah","year":"2019","unstructured":"Nasrallah HA, Fedora R, Morton R (2019) Successful treatment of clozapine-nonresponsive refractory hallucinations and delusions with pimavanserin, a serotonin 5HT-2A receptor inverse agonist. Schizophr Res 208:217\u2013220. https:\/\/doi.org\/10.1016\/j.schres.2019.02.018","journal-title":"Schizophr Res"},{"key":"5485_CR66","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bbr.2012.09.016","volume":"237","author":"Gilda Neves","year":"2013","unstructured":"Neves G, Antonio CB, Betti AH et al (2013) New insights into pharmacological profile of LASSBio-579, a multi-target N-phenylpiperazine derivative active on animal models of schizophrenia. Behav Brain Res 237. https:\/\/doi.org\/10.1016\/j.bbr.2012.09.016","journal-title":"Behavioural Brain Research"},{"key":"5485_CR67","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s00221-006-0503-x","volume":"172","author":"KA Newell","year":"2006","unstructured":"Newell KA, Deng C, Huang X-F (2006) Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia. Exp Brain Res 172:556\u2013560. https:\/\/doi.org\/10.1007\/s00221-006-0503-x","journal-title":"Exp Brain Res"},{"key":"5485_CR68","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1007\/s13311-017-0552-9","volume":"14","author":"FC Nucifora","year":"2017","unstructured":"Nucifora FC, Mihaljevic M, Lee BJ, Sawa A (2017) Clozapine as a model for antipsychotic development. Neurotherapeutics 14:750\u2013761. https:\/\/doi.org\/10.1007\/s13311-017-0552-9","journal-title":"Neurotherapeutics"},{"key":"5485_CR69","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1017\/S1461145711001581","volume":"15","author":"CMP O\u2019Tuathaigh","year":"2012","unstructured":"O\u2019Tuathaigh CMP, Clarke G, Walsh J et al (2012) Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes. Int J Neuropsychopharmacol 15:1331\u20131342. https:\/\/doi.org\/10.1017\/S1461145711001581","journal-title":"Int J Neuropsychopharmacol"},{"issue":"S1","key":"5485_CR70","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1007\/BF02245008","volume":"112","author":"Michael G. Palfreyman","year":"1993","unstructured":"Palfreyman MG, Schmidt CJ, Sorensen SM et al (1993) Electrophysiological, biochemical and behavioral evidence for 5-HT 2 and 5-HT 3 mediated control of dopaminergic function. Psychopharmacology 112. https:\/\/doi.org\/10.1007\/BF02245008","journal-title":"Psychopharmacology"},{"key":"5485_CR71","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3389\/fphar.2016.00303","volume":"7","author":"FF Peres","year":"2016","unstructured":"Peres FF, Levin R, Almeida V et al (2016) Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the shr animal model: implications for schizophrenia pharmacotherapy. Front Pharmacol 7:303. https:\/\/doi.org\/10.3389\/fphar.2016.00303","journal-title":"Front Pharmacol"},{"key":"5485_CR72","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1001\/archpsyc.56.3.277","volume":"56","author":"W Perry","year":"1999","unstructured":"Perry W, Geyer MA, Braff DL (1999) Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients. Arch Gen Psychiatry 56:277\u2013281","journal-title":"Arch Gen Psychiatry"},{"key":"5485_CR73","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1111\/psyp.12679","volume":"53","author":"SL Pineles","year":"2016","unstructured":"Pineles SL, Blumenthal TD, Curreri AJ et al (2016) Prepulse inhibition deficits in women with PTSD. Psychophysiology 53:1377\u20131385. https:\/\/doi.org\/10.1111\/psyp.12679","journal-title":"Psychophysiology"},{"key":"5485_CR74","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/npp.2011.228","volume":"37","author":"BB Quednow","year":"2012","unstructured":"Quednow BB, Kometer M, Geyer MA, Vollenweider FX (2012) Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. Neuropsychopharmacology 37:630\u2013640. https:\/\/doi.org\/10.1038\/npp.2011.228","journal-title":"Neuropsychopharmacology"},{"key":"5485_CR75","first-page":"486","volume":"263","author":"GC Rigdon","year":"1992","unstructured":"Rigdon GC, Weatherspoon JK (1992) 5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex. J Pharmacol Exp Ther 263:486\u2013493","journal-title":"J Pharmacol Exp Ther"},{"key":"5485_CR76","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nrd1346","volume":"3","author":"BL Roth","year":"2004","unstructured":"Roth BL, Sheffler DJ, Kroeze WK (2004) Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov 3:353\u2013359. https:\/\/doi.org\/10.1038\/nrd1346","journal-title":"Nat Rev Drug Discov"},{"key":"5485_CR77","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00008877-200202000-00003","volume":"13","author":"M Schneider","year":"2002","unstructured":"Schneider M, Koch M (2002) The cannabinoid agonist WIN 55,212-2 reduces sensorimotor gating and recognition memory in rats. Behav Pharmacol 13:29\u201337. https:\/\/doi.org\/10.1097\/00008877-200202000-00003","journal-title":"Behav Pharmacol"},{"key":"5485_CR78","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.biopsych.2008.09.026","volume":"65","author":"NA Shanahan","year":"2009","unstructured":"Shanahan NA, Holick Pierz KA, Masten VL et al (2009) Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice. Biol Psychiatry 65:401\u2013408. https:\/\/doi.org\/10.1016\/j.biopsych.2008.09.026","journal-title":"Biol Psychiatry"},{"key":"5485_CR79","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13041-018-0382-7","volume":"11","author":"H Shoji","year":"2018","unstructured":"Shoji H, Miyakawa T (2018) Relationships between the acoustic startle response and prepulse inhibition in C57BL\/6J mice: a large-scale meta-analytic study. Mol Brain 11:42. https:\/\/doi.org\/10.1186\/s13041-018-0382-7","journal-title":"Mol Brain"},{"key":"5485_CR80","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/BF02245096","volume":"117","author":"TA Sipes","year":"1995","unstructured":"Sipes TA, Geyer MA (1995) 8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+)WAY 100,135 and localization of site of action. Psychopharmacology 117:41\u201348. https:\/\/doi.org\/10.1007\/BF02245096","journal-title":"Psychopharmacology"},{"key":"5485_CR81","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0006-8993(97)00316-8","volume":"761","author":"TE Sipes","year":"1997","unstructured":"Sipes TE, Geyer MA (1997) DOI disrupts prepulse inhibition of startle in rats via 5-HT(2A) receptors in the ventral pallidum. Brain Res 761:97\u2013104. https:\/\/doi.org\/10.1016\/S0006-8993(97)00316-8","journal-title":"Brain Res"},{"key":"5485_CR82","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/00008877-199512000-00010","volume":"6","author":"TE Sipes","year":"2006","unstructured":"Sipes TE, Geyer MA (2006) DOI disruption of prepulse inhibition of startle in the rat is mediated by 5-HT2A and not by 5-HT2C receptors. Behav Pharmacol 6:839\u2013842. https:\/\/doi.org\/10.1097\/00008877-199512000-00010","journal-title":"Behav Pharmacol"},{"key":"5485_CR83","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/J.EURONEURO.2012.10.009","volume":"23","author":"R Stancampiano","year":"2013","unstructured":"Stancampiano R, Frau R, Bini V et al (2013) Chronic tryptophan deprivation attenuates gating deficits induced by 5-HT1A, but not 5-HT2 receptor activation. Eur Neuropsychopharmacol 23:1329\u20131335. https:\/\/doi.org\/10.1016\/J.EURONEURO.2012.10.009","journal-title":"Eur Neuropsychopharmacol"},{"key":"5485_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2018.02.042","volume":"198","author":"NR Swerdlow","year":"2018","unstructured":"Swerdlow NR, Light GA (2018) Sensorimotor gating deficits in schizophrenia: advancing our understanding of the phenotype, its neural circuitry and genetic substrates. Schizophr Res 198:1\u20135. https:\/\/doi.org\/10.1016\/j.schres.2018.02.042","journal-title":"Schizophr Res"},{"key":"5485_CR85","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1136\/JNNP.58.2.192","volume":"58","author":"NR Swerdlow","year":"1995","unstructured":"Swerdlow NR, Paulsen J, Braff DL et al (1995) Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 58:192\u2013200. https:\/\/doi.org\/10.1136\/JNNP.58.2.192","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5485_CR86","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1749-6632.1999.tb09269.x","volume":"877","author":"NR Swerdlow","year":"1999","unstructured":"Swerdlow NR, Braff DL, Geyer MA (1999) Cross-species studies of sensorimotor gating of the startle reflex. Ann N Y Acad Sci 877:202\u2013216. https:\/\/doi.org\/10.1111\/j.1749-6632.1999.tb09269.x","journal-title":"Ann N Y Acad Sci"},{"key":"5485_CR87","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s002130100799","volume":"156","author":"NR Swerdlow","year":"2001","unstructured":"Swerdlow NR, Geyer MA, Braff DL (2001a) Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 156:194\u2013215","journal-title":"Psychopharmacology"},{"key":"5485_CR88","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S0006-3223(01)01164-7","volume":"50","author":"NR Swerdlow","year":"2001","unstructured":"Swerdlow NR, Karban B, Ploum Y et al (2001b) Tactile prepuff inhibition of startle in children with Tourette\u2019s syndrome: in search of an \u201cfMRI-friendly\u201d startle paradigm. Biol Psychiatry 50:578\u2013585. https:\/\/doi.org\/10.1016\/S0006-3223(01)01164-7","journal-title":"Biol Psychiatry"},{"key":"5485_CR89","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1001\/archpsyc.63.12.1325","volume":"63","author":"NR Swerdlow","year":"2006","unstructured":"Swerdlow NR, Light GA, Cadenhead KS et al (2006) Startle gating deficits in a large cohort of patients with schizophrenia. Arch Gen Psychiatry 63:1325\u20131335. https:\/\/doi.org\/10.1001\/archpsyc.63.12.1325","journal-title":"Arch Gen Psychiatry"},{"key":"5485_CR90","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/sj.bjp.0705100","volume":"138","author":"ET Tzavara","year":"2003","unstructured":"Tzavara ET, Davis RJ, Perry KW et al (2003) The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions. Br J Pharmacol 138:544\u2013553. https:\/\/doi.org\/10.1038\/sj.bjp.0705100","journal-title":"Br J Pharmacol"},{"key":"5485_CR91","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1021\/cn300118t","volume":"4","author":"M Van Den Buuse","year":"2013","unstructured":"Van Den Buuse M (2013) Exploring the role of 5-HT1A receptors in the regulation of prepulse inhibition in mice: Implications for cross-species comparisons. ACS Chem Neurosci 4:149\u2013160. https:\/\/doi.org\/10.1021\/cn300118t","journal-title":"ACS Chem Neurosci"},{"key":"5485_CR92","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1124\/jpet.106.113084","volume":"320","author":"M van den Buuse","year":"2006","unstructured":"van den Buuse M, Gogos A (2006) Differential effects of antipsychotic drugs on serotonin-1A receptor-mediated disruption of prepulse inhibition. J Pharmacol Exp Ther 320:1224\u20131236. https:\/\/doi.org\/10.1124\/jpet.106.113084","journal-title":"J Pharmacol Exp Ther"},{"key":"5485_CR93","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neulet.2004.10.013","volume":"373","author":"M van den Buuse","year":"2005","unstructured":"van den Buuse M, van Driel IR, Samuelson LC et al (2005) Reduced effects of amphetamine on prepulse inhibition of startle in gastrin-deficient mice. Neurosci Lett 373:237\u2013242. https:\/\/doi.org\/10.1016\/j.neulet.2004.10.013","journal-title":"Neurosci Lett"},{"key":"5485_CR94","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0893-133X(98)00072-4","volume":"20","author":"GB Varty","year":"1999","unstructured":"Varty GB, Bakshi VP, Geyer MA (1999) M100907, a serotonin 5-HT(2A) receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats. Neuropsychopharmacology 20:311\u2013321. https:\/\/doi.org\/10.1016\/S0893-133X(98)00072-4","journal-title":"Neuropsychopharmacology"},{"key":"5485_CR95","doi-asserted-by":"publisher","first-page":"e1002194","DOI":"10.1371\/journal.pbio.1002194","volume":"13","author":"X Vi\u00f1als","year":"2015","unstructured":"Vi\u00f1als X, Moreno E, Lanfumey L et al (2015) Cognitive impairment induced by delta9-tetrahydrocannabinol occurs through heteromers between cannabinoid cb1 and serotonin 5-HT2A receptors. PLoS Biol 13:e1002194. https:\/\/doi.org\/10.1371\/journal.pbio.1002194","journal-title":"PLoS Biol"},{"key":"5485_CR96","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00213-008-1148-1","volume":"198","author":"N Wegener","year":"2008","unstructured":"Wegener N, Kuhnert S, Th\u00fcns A et al (2008) Effects of acute systemic and intra-cerebral stimulation of cannabinoid receptors on sensorimotor gating, locomotion and spatial memory in rats. Psychopharmacology 198:375\u2013385. https:\/\/doi.org\/10.1007\/s00213-008-1148-1","journal-title":"Psychopharmacology"},{"key":"5485_CR97","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.bbr.2005.05.013","volume":"163","author":"BK Yee","year":"2005","unstructured":"Yee BK, Chang T, Pietropaolo S, Feldon J (2005) The expression of prepulse inhibition of the acoustic startle reflex as a function of three pulse stimulus intensities, three prepulse stimulus intensities, and three levels of startle responsiveness in C57BL6\/J mice. Behav Brain Res 163:265\u2013276. https:\/\/doi.org\/10.1016\/j.bbr.2005.05.013","journal-title":"Behav Brain Res"},{"key":"5485_CR98","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/J.PNPBP.2003.11.005","volume":"28","author":"K Zavitsanou","year":"2004","unstructured":"Zavitsanou K, Garrick T, Huang XF (2004) Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 28:355\u2013360. https:\/\/doi.org\/10.1016\/J.PNPBP.2003.11.005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"5485_CR99","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s002130050346","volume":"132","author":"J Zhang","year":"1997","unstructured":"Zhang J, Engel JA, Jackson DM et al (1997) (-)Alprenolol potentiates the disrupting effects of dizocilpine on sensorimotor function in the rat. Psychopharmacology 132:281\u2013288. https:\/\/doi.org\/10.1007\/s002130050346","journal-title":"Psychopharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05485-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-020-05485-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05485-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T00:17:18Z","timestamp":1614039438000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-020-05485-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,24]]},"references-count":99,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["5485"],"URL":"https:\/\/doi.org\/10.1007\/s00213-020-05485-0","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,24]]},"assertion":[{"value":"30 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}